Clinical trial
Study on Regional Structural Changes in the Cerebellum Associated with Blood Biomarkers, Cognitive Decline, and Physical Performance in Alzheimer's Spectrum Patients Following a 3-Month Melatonin Treatment Using Digital Health Technology
NCT06756828 is registered in ClinicalTrials.gov with Saint Vincent's Hospital, Korea as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study on Regional Structural Changes in the Cerebellum Associated with Blood Biomarkers, Cognitive Decline, and Physical Performance in Alzheimer's Spectrum Patients Following a 3-Month Melatonin Treatment Using Digital Health Technology
- Lead sponsor
- Saint Vincent's Hospital, Korea
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- January 15, 2025
- Completion date
- December 30, 2026
- Enrollment
- 40 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
alzheimer disease, biomarker with neurodegeneration patients, cerebellum, cognitive decline, elderly, melatonin